Q2 2019 Holdings
Filed 2019-08-14 | 97 holdings | $299.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Brookdale SR Living Inc(BKD) | COM | 112463104 | $52.0M | 7,207,239 | 17.4% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $39.8M | 281,000 | 13.3% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $37.1M | 1,678,022 | 12.4% |
| Alector Inc(ALEC) | COM | 014442107 | $33.2M | 1,746,923 | 11.1% |
| Biocryst Pharmaceuticals(BCRX) | COM | 09058V103 | $23.9M | 6,292,980 | 8.0% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $20.3M | 921,234 | 6.8% |
| Addus Homecare Corp(ADUS) | COM | 006739106 | $19.0M | 252,915 | 6.3% |
| Axogen Inc(AXGN) | COM | 05463X106 | $17.6M | 891,306 | 5.9% |
| Centene Corp del(CNC) | COM | 15135B101 | $15.9M | 303,000 | 5.3% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $9.3M | 3,461,298 | 3.1% |
| Chewy Inc(CHWY) | CL A | 16679L109 | $9.1M | 261,337 | 3.1% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $8.7M | 3,983,025 | 2.9% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $7.8M | 290,000 | 2.6% |
| Adaptive Biotechnologies COR(ADPT) | COM | 00650F109 | $3.4M | 70,000 | 1.1% |
| Horizon Therapeutics PUB LTD | SHS | G46188101 | $155.5K | 6,462,634 | 0.1% |
| Horizon Pharma Invt LTD | NOTE 2.500% 3/1 | 44052TAB7 | $150.5K | $136,032,000 | 0.1% |
| Mylan N V | SHS EURO | N59465109 | $142.1K | 7,464,327 | 0.0% |
| Orchard Therapeutics PLC | ADS | 68570P101 | $124.8K | 8,923,600 | 0.0% |
| Nevro Corp | NOTE 1.750% 6/0 | 64157FAA1 | $120.6K | $115,776,000 | 0.0% |
| Homology Medicines Inc | COM | 438083107 | $112.7K | 5,760,368 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $89.6K | 3,032,987 | 0.0% |
| Intersect ENT Inc | COM | 46071F103 | $70.8K | 3,109,004 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $69.1K | 4,985,383 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $53.6K | 1,305,174 | 0.0% |
| Insulet Corp | NOTE 1.375%11/1 | 45784PAH4 | $52.1K | 36,650,000 | 0.0% |
| RA Pharmaceuticals Inc | COM | 74933V108 | $51.5K | 1,713,000 | 0.0% |
| Intercept Pharmaceuticals in | NOTE 3.250% 7/0 | 45845PAA6 | $51.4K | $57,791,000 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $50.0K | 997,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $47.0K | 309,025 | 0.0% |
| Diplomat Pharmacy Inc(DPLOEUR) | COM | 25456K101 | $42.9K | 7,036,670 | 0.0% |
| Vericel Corp(VCEL) | COM | 92346J108 | $39.1K | 2,069,601 | 0.0% |
| Mallinckrodt PUB LTD Co | SHS | G5785G107 | $38.4K | 4,178,219 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $36.9K | 391,254 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $34.6K | 1,702,897 | 0.0% |
| Select MED Hldgs Corp(SEM) | COM | 81619Q105 | $32.4K | 2,043,527 | 0.0% |
| Dexcom Inc | NOTE 0.750% 5/1 | 252131AF4 | $31.9K | $20,000,000 | 0.0% |
| Kempharm Inc | NOTE 5.500% 2/0 | 488445AB3 | $31.6K | $65,423,000 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $30.5K | 540,529 | 0.0% |
| Editas Medicine Inc(EDIT) | COM | 28106W103 | $28.7K | 1,158,841 | 0.0% |
| Sientra Inc | COM | 82621J105 | $28.7K | 4,652,306 | 0.0% |
| Natera Inc(NTRA) | COM | 632307104 | $27.7K | 1,002,834 | 0.0% |
| PTC Therapeutics Inc | NOTE 3.000% 8/1 | 69366JAB7 | $27.6K | $24,877,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $27.3K | 264,600 | 0.0% |
| Xeris Pharmaceuticals Inc | COM | 98422L107 | $27.2K | 2,379,901 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $27.0K | 1,217,668 | 0.0% |
| Ehealth Inc(EHTH) | COM | 28238P109 | $26.8K | 310,900 | 0.0% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $26.3K | 3,201,222 | 0.0% |
| DFB Healthcare Acquistion Co | UNIT 01/30/2023 | 23291E208 | $25.9K | 2,500,000 | 0.0% |
| Exact Sciences Corp | NOTE 1.000% 1/1 | 30063PAA3 | $25.8K | $15,000,000 | 0.0% |
| Staar Surgical Co(STAA) | COM | 852312305 | $25.8K | 876,512 | 0.0% |